follow-on biologics

Blood Drug Woes Could Weigh on FDA and its Approval of New, Copycat Biologic Medicines
Forbes
Mon, 02/25/13 - 10:13 am
FDA
drug approvals
Omontys
follow-on biologics
Affymax
Merck's Ditching of Aranesp Biosimilar Highlights Follow-on-Biologics Pitfalls
Seeking Alpha
Mon, 05/17/10 - 09:57 am
follow-on biologics
Aranesp
Merck
Amgen
Teva Pharmaceuticals
anemia
Pfizer's Future: Biotech Follow-ups
Seeking Alpha
Wed, 04/28/10 - 06:01 pm
Pfizer
follow-on biologics
FTC Report on Follow-on Biologics Sparks Congressional Debate
PharmTech.com
Thu, 06/18/09 - 09:56 am
FTC
follow-on biologics